[{"question": "An investigator is conducting an experiment to develop a new drug against HIV infection. HIV-infected and uninfected CD4 T-cell lines are mixed in-vitro with a chemically modified synthetic peptide triazole complex. The complex is found to have a high binding affinity to the gp120 protein, irreversibly inhibiting its function and reducing CD4 T cell infection. Inhibition of which of the following steps of HIV infection is the most likely therapeutic effect of this experimental drug?", "correct_answer": "Attachment to host CD4 T-cells", "correct_idx": 3, "options": ["A)Incorporation of viral genome into host cell DNA", "B)Transcription of the viral genome", "C)Fusion and entry into CD4 T-cells", "D)Attachment to host CD4 T-cells"], "prompt": "An investigator is conducting an experiment to develop a new drug against HIV infection. HIV-infected and uninfected CD4 T-cell lines are mixed in-vitro with a chemically modified synthetic peptide triazole complex. The complex is found to have a high binding affinity to the gp120 protein, irreversibly inhibiting its function and reducing CD4 T cell infection. Inhibition of which of the following steps of HIV infection is the most likely therapeutic effect of this experimental drug?A)Incorporation of viral genome into host cell DNA\nB)Transcription of the viral genome\nC)Fusion and entry into CD4 T-cells\nD)Attachment to host CD4 T-cells", "subject_name": null, "output0": "The experimental drug works by inhibiting the function of the gp120 protein, which is a critical step in the HIV infection process. By inhibiting the function of gp120, the drug is likely to prevent the incorporation of the viral genome into host cell DNA, thereby reducing the ability of the virus to replicate and infect new cells. This therapeutic effect is most likely to occur at the step of incorporation of viral genome into host cell DNA.\n\n", "output1": "The experimental drug inhibits the function of gp120, which is a critical component of the HIV envelope protein that is involved in the attachment and entry of the virus into CD4 T-cells. By inhibiting the function of gp120, the drug likely reduces the transcription of the viral genome, which is a critical step in the HIV replication cycle.\n\n", "output2": "The experimental drug is found to have a high binding affinity to the gp120 protein, which is a surface protein of HIV that is involved in the fusion and entry of the virus into CD4 T-cells. By irreversibly inhibiting the function of this protein, the drug is likely to prevent the fusion and entry of HIV into CD4 T-cells, thereby reducing the infection of these cells.\n\n", "output3": "The experimental drug inhibits the attachment of HIV to CD4 T-cells, which is step D of the HIV infection process. By inhibiting this step, the drug reduces the ability of HIV to infect CD4 T-cells, which is the most likely therapeutic effect of the drug.\n\n"}, {"question": "Which of the following non-characterized Turner's syndrome Turner syndrome it?", "correct_answer": "Acne hyperplasia", "correct_idx": 3, "options": ["A)Short stature", "B)Amenorrhea", "C)Infertility", "D)Acne hyperplasia"], "prompt": "Which of the following non-characterized Turner's syndrome Turner syndrome it?A)Short stature\nB)Amenorrhea\nC)Infertility\nD)Acne hyperplasia", "subject_name": null, "output0": "Short stature is a common feature of Turner syndrome, which is a genetic disorder that affects females. It is characterized by a missing or partially deleted X chromosome, which can result in short stature, as well as other physical and developmental abnormalities.\n\n", "output1": "Amenorrhea is a common feature of Turner syndrome, and it is often used as a diagnostic criterion for the condition.\n\n", "output2": "Infertility is a common feature of Turner syndrome, a genetic disorder that affects females. It is caused by a missing or partially deleted X chromosome, which can result in the absence of ovarian development and infertility.\n\n", "output3": "Turner syndrome is a genetic disorder that affects females and is characterized by short stature, amenorrhea, infertility, and other physical and developmental abnormalities. Acne hyperplasia is not a characteristic of Turner syndrome.\n\n"}, {"question": "What can be the use of a periodontal probe?", "correct_answer": "All of the above", "correct_idx": 3, "options": ["A)Measurement of probing depth if a sulcus", "B)Determination of topography of the JE", "C)Measurement of the width of attached gingiva", "D)All of the above"], "prompt": "What can be the use of a periodontal probe?A)Measurement of probing depth if a sulcus\nB)Determination of topography of the JE\nC)Measurement of the width of attached gingiva\nD)All of the above", "subject_name": "Dental", "output0": "A periodontal probe is used to measure the depth of the sulcus, which is the space between the teeth and the gum line. This is an important measurement to determine the health of the teeth and the gums.\n\n", "output1": "A periodontal probe is used to measure the depth of the sulcus, which is an important aspect of periodontal examination.\n\n", "output2": "A periodontal probe can be used to measure the width of attached gingiva, which is an important aspect of periodontal assessment.\n\n", "output3": "A periodontal probe can be used to measure the probing depth of a sulcus, determine the topography of the junctional epithelium (JE), and measure the width of attached gingiva. Therefore, the correct answer is D)All of the above.\n\n"}, {"question": "\u03b2-oxidation of odd-chain fatty acids produce:", "correct_answer": "Propionyl CoA", "correct_idx": 1, "options": ["A)Succinyl CoA", "B)Propionyl CoA", "C)Acetyl CoA", "D)Malonyl CoA"], "prompt": "\u03b2-oxidation of odd-chain fatty acids produce:A)Succinyl CoA\nB)Propionyl CoA\nC)Acetyl CoA\nD)Malonyl CoA", "subject_name": "Biochemistry", "output0": "The \u03b2-oxidation of odd-chain fatty acids produces succinyl CoA, which is then converted into succinate through the action of the enzyme succinyl-CoA synthetase.\n\n", "output1": "\u03b2-oxidation of odd-chain fatty acids produces Propionyl CoA. This is because propionyl CoA is the product of the oxidation of odd-chain fatty acids, which have an odd number of carbon atoms.\n\n", "output2": "\u03b2-oxidation of odd-chain fatty acids produces acetyl-CoA, which is then used to produce energy in the form of ATP.\n\n", "output3": "\u03b2-oxidation of odd-chain fatty acids produces Malonyl CoA, which is then converted to Acetyl CoA through the action of acetyl-CoA carboxylase.\n\n"}, {"question": "Type of mouth breathing can be:", "correct_answer": "All of the above.", "correct_idx": 3, "options": ["A)Obstructive.", "B)Anatomic.", "C)Habitual.", "D)All of the above."], "prompt": "Type of mouth breathing can be:A)Obstructive.\nB)Anatomic.\nC)Habitual.\nD)All of the above.", "subject_name": "Dental", "output0": "Obstructive mouth breathing is a type of mouth breathing that occurs when the airway is partially or completely blocked, causing the child to breathe through their mouth instead of their nose. This can be due to a variety of factors, such as allergies, colds, or a deviated septum.\n\n", "output1": "Mouth breathing can be anatomic or habitual. Anatomic mouth breathing occurs when the mouth is used to breathe due to a physical obstruction in the nasal passages, such as a cold or allergies. Habitual mouth breathing, on the other hand, is when the mouth is used to breathe as a habit, often due to poor oral posture or other factors.\n\n", "output2": "Habitual mouth breathing is a type of mouth breathing that is done unconsciously and often without the person realizing it. It can be caused by a variety of factors, such as allergies, sinus infections, or a deviated septum.\n\n", "output3": "Type of mouth breathing can be obstructive, anatomic, and habitual. Obstructive mouth breathing occurs when the airway is physically blocked, such as when the tongue or other soft tissue in the mouth obstructs the airflow. Anatomic mouth breathing occurs when the shape of the mouth or throat prevents the air from flowing freely. Habitual mouth breathing is when a person breathes through their mouth due to a habit or preference, rather than through their nose.\n\n"}, {"question": "Which new generation sialagogue has additional M3 action?", "correct_answer": "Cevimeline", "correct_idx": 3, "options": ["A)Hyoscine", "B)Cinnarizine", "C)Promethazine", "D)Cevimeline"], "prompt": "Which new generation sialagogue has additional M3 action?A)Hyoscine\nB)Cinnarizine\nC)Promethazine\nD)Cevimeline", "subject_name": "Radiology", "output0": "Hyoscine is a new generation sialagogue that has additional M3 action, which is helpful for treating dry mouth and other symptoms associated with neurological disorders.\n\n", "output1": "Cinnarizine is a new generation sialagogue that has additional M3 action. It works by increasing the amount of saliva produced in the mouth, which can help to improve swallowing and reduce the risk of respiratory complications.\n\n", "output2": "Promethazine is a new generation sialagogue that has additional M3 action, which helps to increase saliva production and improve dry mouth symptoms.\n\n", "output3": "Cevimeline is a new generation sialagogue that has been shown to have additional M3 action. This makes it a more effective option for treating dry mouth and other symptoms of dysphagia.\n\n"}, {"question": "At 10 o'clock in the morning a serum sample is analyzed and a total bilirubin concentration of 12 mg / dL (205.6 \u03bcmol / L) is obtained. The same sample is reanalyzed at 3 o'clock in the afternoon and the result of bilirubin is 8 mg / dL (136.8 \u03bcmol / L). Indicate which is the most reasonable explanation that justifies this discrepancy:", "correct_answer": "Sample exposed to light.", "correct_idx": 1, "options": ["A)Deterioration of the reagent.", "B)Sample exposed to light.", "C)Calculation error in the first analysis.", "D)Sample not refrigerated."], "prompt": "At 10 o'clock in the morning a serum sample is analyzed and a total bilirubin concentration of 12 mg / dL (205.6 \u03bcmol / L) is obtained. The same sample is reanalyzed at 3 o'clock in the afternoon and the result of bilirubin is 8 mg / dL (136.8 \u03bcmol / L). Indicate which is the most reasonable explanation that justifies this discrepancy:A)Deterioration of the reagent.\nB)Sample exposed to light.\nC)Calculation error in the first analysis.\nD)Sample not refrigerated.", "subject_name": "pharmacology", "output0": "The discrepancy between the two bilirubin measurements is likely due to the deterioration of the reagent used in the first analysis. The reagent may have degraded over time, leading to an inaccurate measurement of bilirubin. This is a common source of error in laboratory testing.\n\n", "output1": "The discrepancy between the two results is likely due to the sample being exposed to light, which can cause the bilirubin concentration to increase. This is because bilirubin is a light-sensitive molecule that can undergo photo-oxidation, leading to an increase in its concentration.\n\n", "output2": "The discrepancy in the results of the two analyses is likely due to a calculation error in the first analysis. Bilirubin concentrations are typically measured in micromoles per liter (\u03bcmol/L), and a mistake in the calculation could result in an incorrect value.\n\n", "output3": "The discrepancy in the results of the two analyses is likely due to the sample not being refrigerated. Bilirubin is a labile substance and can degrade over time, especially when exposed to light and heat. The sample was analyzed at 10 am and the results were not refrigerated, which may have caused the degradation of the bilirubin and the resultant discrepancy in the second analysis.\n\n"}, {"question": "What processing should be done of the blood before transfusion to reduce chances of febrile non-hemolytic transfusion reaction (FNHTR)?", "correct_answer": "Leucocyte reduction", "correct_idx": 2, "options": ["A)Irradiation", "B)Washing", "C)Leucocyte reduction", "D)Glycolisation"], "prompt": "What processing should be done of the blood before transfusion to reduce chances of febrile non-hemolytic transfusion reaction (FNHTR)?A)Irradiation\nB)Washing\nC)Leucocyte reduction\nD)Glycolisation", "subject_name": "Pathology", "output0": "Irradiation is the recommended method for reducing the risk of FNHTR. This process involves exposing the blood to ionizing radiation, which kills bacteria and other pathogens that may be present in the blood.\n\n", "output1": "Washing the blood before transfusion can help reduce the risk of FNHTR by removing any bacteria or viruses that may be present in the blood. This is because FNHTR is often caused by infectious agents that are transmitted through the blood.\n\n", "output2": "Leucocyte reduction is the most effective way to reduce the risk of FNHTR. This technique involves removing the white blood cells from the donated blood, which are the primary cause of FNHTR.\n\n", "output3": "The correct answer is D)Glycolisation. Glycolysis is the process of converting glucose into energy. This process reduces the amount of potassium in the blood, which can contribute to the development of FNHTR. By glycolysing the blood, the amount of potassium in the blood can be reduced, reducing the risk of FNHTR.\n\n"}, {"question": "Strawberry gums are seen in", "correct_answer": "Wegener's granulomatosis", "correct_idx": 2, "options": ["A)Goodpasteur's syndrome", "B)Classic polyaeritis nodosa", "C)Wegener's granulomatosis", "D)Kawasaki syndrome"], "prompt": "Strawberry gums are seen inA)Goodpasteur's syndrome\nB)Classic polyaeritis nodosa\nC)Wegener's granulomatosis\nD)Kawasaki syndrome", "subject_name": "Pathology", "output0": "Strawberry gums are a characteristic feature of Goodpasteur's syndrome. It is a rare genetic disorder that affects the skin and mucous membranes. The strawberry gums are caused by the accumulation of abnormal lipids in the skin, which gives it a characteristic appearance.\n\n", "output1": "Strawberry gums are a characteristic symptom of classic polyaeritis nodosa, which is a rare autoimmune disease that affects the skin and mucous membranes. The gums become swollen and take on a reddish-purple color, resembling strawberries.\n\n", "output2": "Wegener's granulomatosis is a rare autoimmune disorder that affects the blood vessels and can cause a variety of symptoms, including the formation of strawberry gums.\n\n", "output3": "Strawberry gums are a characteristic feature of Kawasaki syndrome, a rare autoimmune disease that affects children. The gums become swollen and take on a strawberry-like appearance due to the inflammation of the blood vessels.\n\n"}, {"question": "Amount of chlorhexidine gluconates been incorporated per chip in periochip is?", "correct_answer": "2.5 mg", "correct_idx": 1, "options": ["A)3 mg", "B)2.5 mg", "C)2 mg", "D)1.5 mg"], "prompt": "Amount of chlorhexidine gluconates been incorporated per chip in periochip is?A)3 mg\nB)2.5 mg\nC)2 mg\nD)1.5 mg", "subject_name": "Dental", "output0": "The amount of chlorhexidine gluconate incorporated per chip in PerioChip is 3 mg. This is the amount that has been found to be effective in reducing plaque and gingivitis.\n\n", "output1": "The amount of chlorhexidine gluconate incorporated per chip in PerioChip is 2.5 mg. This amount has been found to be effective in reducing plaque and gingival inflammation, while also being well tolerated by patients.\n\n", "output2": "The amount of chlorhexidine gluconate incorporated per chip in periochip is 2 mg. This is the recommended amount for effective antimicrobial action without causing toxicity or irritation to the oral tissues.\n\n", "output3": "The amount of chlorhexidine gluconate incorporated per chip in PerioChip is 1.5 mg. This is the amount of the active ingredient that is included in each chip, which is designed to provide effective antimicrobial protection against periodontal pathogens.\n\n"}]